Molgramostim not recommended for febrile neutropenia Newsletter Article 15 February 2013 Pages: 6 - 6
Dual benefits of ACE inhibitor therapy in heart failure Gill Higgins Newsletter Article 15 February 2013 Pages: 7 - 7
Immunoprophylaxis cost saving in children with recurrent URTI Newsletter Article 15 February 2013 Pages: 8 - 8
Updating progress towards a breast cancer vaccine Tracey Wright Newsletter Article 15 February 2013 Pages: 9 - 9
KF-19514: ‘potent’ effect in guinea pig model of asthma Newsletter Article 15 February 2013 Pages: 10 - 10
Triple anti-HIV regimen improves viral load and clinical outcomes Newsletter Article 15 February 2013 Pages: 12 - 12
Urapidil vs dihydralazine in severe hypertension in pregnancy Newsletter Article 15 February 2013 Pages: 14 - 14
Lepirudin ‘superior’ to heparin in ischaemia without ST elevation Newsletter Article 15 February 2013 Pages: 15 - 15
Methotrexate and salpingostomy effective in tubal pregnancy Newsletter Article 15 February 2013 Pages: 15 - 15
ACE inhibitors beneficial in nondiabetic renal disease Newsletter Article 15 February 2013 Pages: 16 - 16
MAO inhibitors: rapid switching possible in selected patients Newsletter Article 15 February 2013 Pages: 17 - 17
Prolonged response to pramipexole without levodopa Newsletter Article 15 February 2013 Pages: 18 - 18
Intrapleural paclitaxel feasible in malignant pleural effusion Newsletter Article 15 February 2013 Pages: 18 - 18
Inhaled corticosteroids and cortisol suppression examined Newsletter Article 15 February 2013 Pages: 19 - 19
Response to somatropin in uraemic patients on haemodialysis Newsletter Article 15 February 2013 Pages: 19 - 19
Busulfan: limited-sampling for paediatric monitoring Newsletter Article 15 February 2013 Pages: 20 - 20
US FDA to waive non-serious adverse event reporting Newsletter Article 15 February 2013 Pages: 20 - 20
Tolcapone approved in Europe for Parkinson’s disease Newsletter Article 15 February 2013 Pages: 21 - 21